https://www.prnewswire.com/news-releases/acepodia-presents-preclinical-data-on-antibody-dual-drugs-conjugation-ad2c-technology-at-aacr-annual-meeting-2025-302433216.html
Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR...
Apr 21, 2025 - /PRNewswire/ -- Acepodia (6976: TT) today announced the presentation of new preclinical data highlighting its proprietary dual-payload antibody-drug...
preclinical dataacepodiapresentsantibodydual
https://www.sitryx.com/news/sitryx-presents-new-preclinical-data-highlighting-pkm2-as-a-promising-metabolic-target-for-the-treatment-of-atopic-dermatitis-at-the-inflammatory-disease-skin-summit-2025
Sitryx presents new preclinical data highlighting PKM2 as a promising metabolic target for the...
presents newpreclinical datasitryxhighlightingpromising
https://www.bioqubeventures.com/egle-therapeutics-to-present-new-preclinical-data-egl-003/
Egle Therapeutics to Present New Preclinical Data EGL-003, a Novel IL-2 Mutein for Selective...
Oct 6, 2025 - Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases
present newpreclinical dataegletherapeuticsnovel
https://www.prnewswire.com/news-releases/acepodia-to-present-preclinical-data-on-its-gamma-delta-t-cell-therapy-candidate-ace1831-at-2022-sitc-annual-meeting-301667249.html
Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022...
Nov 3, 2022 - /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC)...
preclinical datacell therapyacepodiapresentgamma
https://imouse.info/
iMouse - Preclinical Data Accuracy
In Preclinical Research, Translatability is Everything. enhance objectivity now! In research that shapes the future of medicine, subjective results are not...
preclinical dataaccuracy
https://www.sitryx.com/news/sitryx-presents-new-preclinical-data-highlighting-mthfd2-as-a-novel-metabolic-target-in-autoimmune-disease-at-acr-convergence-2025
Sitryx presents new preclinical data highlighting MTHFD2 as a novel metabolic target in autoimmune...
presents newpreclinical datasitryxhighlightingnovel